Racial differences and geographic variations in oral anticoagulation treatment among Medicare patients with non-valvular atrial fibrillation.
<h4>Introduction</h4>Use of oral anticoagulants (OACs) for stroke reduction in atrial fibrillation (AF) varies by race and geography within the United States. We seek to better understand the relationship between OAC underutilization, race, and US geography.<h4>Methods</h4>Pa...
Saved in:
| Main Authors: | Larry R Jackson, Amiee Kang, Virginia Noxon, Nipun Atreja, Dionne M Hines, Melissa Hagan, Jenny Jiang, Brett D Atwater |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0314345 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
US cost–effectiveness analysis of apixaban compared with warfarin, dabigatran and rivaroxaban for nonvalvular atrial fibrillation, focusing on equal value of life years and health years in total
by: Nipun Atreja, et al.
Published: (2024-11-01) -
Cost-effectiveness analysis of anticoagulation options for non-valvular atrial fibrillation in Iran
by: Satar Rezaei, et al.
Published: (2024-11-01) -
Timing of oral anticoagulation in acute ischaemic stroke and non-valvular atrial fibrillation: early, ‘timely’ or late?
by: Gregory Y H Lip, et al.
Published: (2024-12-01) -
Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK
by: Mar Martín-Pérez, et al.
Published: (2019-09-01) -
Comparative safety and effectiveness of oral anticoagulants in patients with non-valvular atrial fibrillation and high risk of gastrointestinal bleeding: A nationwide French cohort study.
by: Gregory Y H Lip, et al.
Published: (2024-01-01)